BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-85@pharmaconomics
DTSTAMP:20260707T003350Z
DTSTART;VALUE=DATE:20261001
DTEND;VALUE=DATE:20261002
SUMMARY:COCP Phase 2 — CDI-988
DESCRIPTION:Phase 2 trial results for CDI-988 in Norovirus are due Oct 1\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT07198139\n\nTrack it: https://pharmaconomics.com/e/85
URL:https://pharmaconomics.com/e/85
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:COCP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR